Skip to content
LodeRx
LodeRx oral tirzepatide ODT product render
503A COMPOUNDEDDAILY TABLET
PRESCRIPTION DUAL-AGONIST · NO NEEDLES

Maximum strength.
Minimum hassle.

Tirzepatide — a dual-pathway GIP/GLP-1 receptor agonist — as a daily tablet that dissolves under the tongue. No injections, same clinician oversight.

Dual-pathway appetite control, zero needles
One small tablet a day, no cold storage
Clinician-set dose, adjusted to how you respond
Consultation, medication, and shipping included
Choose your planLonger = lower per month
Get started →
Answer a few health questions & check out securely with Ola · opens in a new tab
Physician, care team, medication & free cold shipping — includedBloodwork included where the protocol requires itNo contracts — cancel before your next renewal

Prescribed only when clinically appropriate, at a licensed provider's discretion. Not available in Washington, DC. Prefer the once-weekly injection? See tirzepatide injection →

WHAT TO EXPECT

The strong option, made simple.

Calm, tidy kitchen
A tablet, then breakfast

Dissolves under the tongue each morning and works both appetite pathways — GLP-1 and GIP — through the day.

Person walking outdoors
The scale keeps moving

Tirzepatide's dual mechanism has produced some of the largest average weight reductions in its class — the tablet keeps that science, drops the needle.

Confident, active person
Nothing to psych up for

No injection day, no sharps, no refrigeration routine. The habit is the easy part, which is how habits survive.

THE SCIENCE

How oral tirzepatide works.

Plain answers to what your clinician will cover, no forum myths.

What is tirzepatide ODT?

ODT means orally disintegrating tablet — compounded tirzepatide in a daily tablet that dissolves under your tongue. A dual GIP/GLP-1 receptor agonist prepared by state-licensed US compounding pharmacies under Section 503A of the FD&C Act. Compounded medications are not FDA-approved.

How is it different from oral semaglutide?

Semaglutide works one appetite pathway; tirzepatide works two. The added GIP pathway influences appetite and energy handling — often the pick when there's more weight to move or single-pathway therapy plateaued. Your clinician helps you choose.

Is it right for me?

Typically for adults with a qualifying BMI or weight-related condition — your clinician decides from your history. A personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or pregnancy are among the reasons it may not be appropriate.

What about side effects?

Same class profile: gastrointestinal effects — nausea, constipation, reflux — mostly during dose ramp, easing over time for most people. Your clinician manages the ramp and adjusts when needed.

HOW IT STARTS

Three steps, no sharps container.

1
Start online

Choose your plan and complete a short medical intake — history, weight goals, any conditions. Prefer to talk first? Request a call.

2
Clinician review

A provider licensed in your state reviews your file and decides if oral tirzepatide is the right tool for your case.

3
Ships to your door

Tablets arrive from a certified US pharmacy. Take one daily; your care team handles check-ins and dose steps.

QUESTIONS

Asked constantly. Answered honestly.

How do I take it?

One tablet under the tongue daily, at a consistent time. It dissolves on its own — no water, no prep, no refrigeration.

Tablet or injection — which should I pick?

Clinically they use the same compounded molecule and titration logic. Pick the format you'll actually stick with: daily tablet if needles are a barrier, once-weekly injection if you'd rather think about it four times a month.

How fast will I see results?

Appetite changes often show in the first few weeks; weight change builds over months as the dose titrates. Steady beats dramatic — it stays off.

Can I use HSA/FSA, and can I stop?

Many members use HSA/FSA funds — check your plan. No contracts; cancel before your next renewal. If you stop, your clinician advises on maintenance and what to expect.

ORAL TIRZEPATIDE, DONE RIGHT

All the strength.
None of the sting.

Daily tablet, dual-pathway GIP/GLP-1 receptor agonist
Clinician-titrated, check-ins included
From $209/mo, no hidden fees
No contracts, cancel anytime
STAY IN THE KNOW

Deals, new science, and new programs.

Join the list for member pricing, the latest research on hormones and longevity, and first access to new programs.

No spam. Unsubscribe anytime. See our Privacy Policy.